Hepatocellular carcinoma or interferon-based therapy history attenuates sofosbuvir/ribavirin for Japanese genotype 2 hepatitis C virus-Reference-Cited by-同舟云学术

Hepatocellular carcinoma or interferon-based therapy history attenuates sofosbuvir/ribavirin for Japanese genotype 2 hepatitis C virus

Published:2018-04-07 Issue:13 Volume:24 Page:1478-1485
ISSN:1007-9327
Container-title:World Journal of Gastroenterology
language:
Short-container-title:WJG

Author:

Yada Masayoshi,Miyazaki Masayuki,Tanaka Kosuke,Masumoto Akihide,Motomura Kenta

Publisher

Baishideng Publishing Group Inc.

Subject

Gastroenterology,General Medicine

Reference22 articles.

1. World Health Organization. Global hepatitis report, 2017. 2017 Available from: URL: http://www.who.int/hepatitis/publications/global-hepatitis-report2017/en/

2. Historical epidemiology of hepatitis C virus (HCV) in select countries - volume 3

3. Response-guided peginterferon-alpha-2b plus ribavirin therapy for chronic hepatitis C patients with genotype 2 and high viral loads

4. Efficacy of telaprevir-based therapy for difficult-to-treat patients with genotype 2 chronic hepatitis C in Japan

5. Sofosbuvir plus ribavirin in Japanese patients with chronic genotype 2 HCV infection: an open‐label, phase 3 trial

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of direct‐acting antiviral therapy for hepatitis C virus in elderly patients (≥65 years old): A systematic review and meta‐analysis;Journal of Viral Hepatitis;2022-04-06

2. Incidence, risk factors and impact on virological response of anemia in chronic genotype 2 hepatitis C receiving sofosbuvir plus ribavirin;Journal of the Formosan Medical Association;2020-01

3. Systematic review with meta-analysis: mortality in acute severe ulcerative colitis;Alimentary Pharmacology & Therapeutics;2019-12-10

4. Systematic review with meta-analysis: effectiveness of direct-acting antiviral treatment for hepatitis C in patients with hepatocellular carcinoma;Alimentary Pharmacology & Therapeutics;2019-12-06

5. Sustained virologic response to direct-acting antiviral therapy in patients with chronic hepatitis C and hepatocellular carcinoma: A systematic review and meta-analysis;Journal of Hepatology;2019-09